review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.PLACENTA.2008.06.011 |
P8608 | Fatcat ID | release_xt5trxet4vhorlrr3lspzd4wx4 |
P932 | PMC publication ID | 2614866 |
P698 | PubMed publication ID | 18687466 |
P5875 | ResearchGate publication ID | 23156314 |
P2093 | author name string | Y Xia | |
R A Irani | |||
P2860 | cites work | Placental ischemia and soluble fms-like tyrosine kinase 1: cause or consequence of preeclampsia? | Q80316215 |
Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension | Q80361560 | ||
Role of oxygen and vascular development in epithelial branching morphogenesis of the developing mouse lung | Q80585977 | ||
Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia | Q82705098 | ||
Determination of the primary structures of human skin chymase and cathepsin G from cutaneous mast cells of urticaria pigmentosa lesions | Q24309784 | ||
Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor | Q24320710 | ||
Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. | Q24537348 | ||
Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart | Q28114921 | ||
Selective conversion of big endothelins to tracheal smooth muscle-constricting 31-amino acid-length endothelins by chymase from human mast cells | Q28246224 | ||
Endothelin 1 and angiotensin II in preeeclampsia | Q28306251 | ||
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney | Q30471269 | ||
Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo | Q31404999 | ||
Free radicals and antioxidants in the year 2000. A historical look to the future | Q33180577 | ||
Oxidative stress in the pathogenesis of preeclampsia | Q33796834 | ||
The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis | Q33838726 | ||
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. | Q33853208 | ||
Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen--a review. | Q33930029 | ||
Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3) | Q33939664 | ||
Placental debris, oxidative stress and pre-eclampsia | Q34032003 | ||
Structure and function of VEGF/VEGF-receptor system involved in angiogenesis | Q34246910 | ||
The human mast cell chymase gene (CMA1): mapping to the cathepsin G/granzyme gene cluster and lineage-restricted expression | Q34362936 | ||
Latest advances in understanding preeclampsia | Q34425288 | ||
A study of angiotensin II pressor response throughout primigravid pregnancy | Q34512573 | ||
Comparative developmental anatomy of the murine and human definitive placentae. | Q34546263 | ||
Human decidua is a major source of renin | Q34575720 | ||
Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis | Q34708320 | ||
Oxygen, early embryonic metabolism and free radical-mediated embryopathies | Q35081401 | ||
Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling | Q35681804 | ||
AT1 receptor heterodimers and angiotensin II responsiveness in preeclampsia | Q35689550 | ||
Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy | Q35699115 | ||
Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome | Q35750283 | ||
Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis | Q35763556 | ||
Plasminogen activator inhibitor 1, fibrin, and the vascular response to injury | Q35840308 | ||
Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question | Q35920602 | ||
Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice | Q36311525 | ||
Genetic progress towards the molecular basis of autoimmunity. | Q36368037 | ||
Inflammation and pre-eclampsia | Q36530771 | ||
The immune system and happiness. | Q36617511 | ||
Inflammatory response in preeclampsia | Q36833207 | ||
Activation of local chorionic villi angiotensin II levels but not angiotensin (1-7) in preeclampsia | Q37250421 | ||
Cellular localization of AT1 receptor mRNA and protein in normal placenta and its reduced expression in intrauterine growth restriction. Angiotensin II stimulates the release of vasorelaxants | Q37377636 | ||
Control of vascular responsiveness during human pregnancy | Q40122647 | ||
Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia | Q40530224 | ||
The uteroplacental renin-angiotensin system: a review | Q40652280 | ||
Angiotensin II inhibits human trophoblast invasion through AT1 receptor activation | Q40735093 | ||
Metabolism alters the selectivity of angiotensin-(1-7) receptor ligands for angiotensin receptors. | Q40867054 | ||
Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction | Q40968880 | ||
Preeclampsia: an endothelial cell disorder | Q41281924 | ||
Sodium excretion in normal and hypertensive pregnancy: a prospective study | Q41976105 | ||
Lymphocyte intracellular free calcium concentration is increased in preeclampsia | Q42472176 | ||
Effect of angiotensin II synthesis blockade on the hypertensive response to chronic reductions in uterine perfusion pressure in pregnant rats. | Q43744800 | ||
Production of human mast cell chymase in human myometrium and placenta in cases of normal pregnancy and preeclampsia | Q43891523 | ||
Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells | Q44320558 | ||
AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase | Q44385661 | ||
Apoptotic cascade initiated by angiotensin II in neonatal cardiomyocytes: role of DNA damage | Q44550393 | ||
Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation | Q45069619 | ||
Increased intracellular free calcium and sensitivity to angiotensin II in platelets of preeclamptic women | Q46136176 | ||
Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion | Q46344658 | ||
Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness | Q46841539 | ||
Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion | Q46877931 | ||
Circulating angiogenic factors and the risk of preeclampsia | Q47217679 | ||
Agonistic AT1 receptor autoantibodies and monocyte stimulation in hypertensive patients*1 | Q47447775 | ||
Endothelial dysfunction in preeclampsia | Q47879591 | ||
The human placental renin-angiotensin system | Q48430627 | ||
Vascular endothelial growth factor and placental growth factor release in cultured trophoblast cells under different oxygen tensions. | Q51676467 | ||
Characterization of a new selective antagonist for angiotensin-(1-7), D-pro7-angiotensin-(1-7). | Q51839155 | ||
Molecular evidence of placental hypoxia in preeclampsia. | Q51975690 | ||
Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. | Q52940276 | ||
Physiological and pharmacological implications of AT1 versus AT2 receptors. | Q54125354 | ||
Increased chymotrypsin-like protease (chymase) expression and activity in placentas from women with preeclampsia. | Q54601823 | ||
Dysregulation of the Circulating and Tissue-Based Renin-Angiotensin System in Preeclampsia | Q56981959 | ||
Production of Renin by in vitro Cultures of Human Chorion and Uterine Muscle | Q59058046 | ||
Morphometric analysis of pre-eclampsia in women biopsied in pregnancy and post-partum | Q67982464 | ||
Renin-aldosterone relationships in pregnancy-induced hypertension | Q68044331 | ||
A renin-like substance in the human placenta | Q68564317 | ||
Immunofluorescent Studies in Renal Biopsies in Pre-eclampsia | Q69331622 | ||
Erythrocyte cation metabolism in preeclampsia | Q69354420 | ||
Changes in active and inactive renin throughout pregnancy | Q70219673 | ||
Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR | Q71530460 | ||
Prostaglandins stimulate renin secretion and renin mRNA in mouse renal juxtaglomerular cells | Q71645969 | ||
Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen | Q71695937 | ||
Calcium metabolism in pre-eclampsia | Q73225217 | ||
Reproductive tissue renin gene expression in preeclampsia | Q73300232 | ||
Recent chymase inhibitors and their effects in in vivo models | Q73510604 | ||
Effect of a novel vasoconstrictor endothelin-1 (1-31) on human umbilical artery | Q73642545 | ||
AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
Expression of inflammatory cytokines in placentas from women with preeclampsia | Q73992120 | ||
Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension | Q74126541 | ||
Definitive molecular evidence of renin-angiotensin system in human uterine decidual cells | Q74188076 | ||
Plasma active renin, angiotensin I, and angiotensin II during pregnancy and in preeclampsia | Q74195115 | ||
An essential role for angiotensin II type 1a receptor in pregnancy-associated hypertension with intrauterine growth retardation | Q75197234 | ||
Induction of urokinase receptor expression in nephrotoxic nephritis | Q77149613 | ||
Pregnancy-induced changes in renin gene expression in mice | Q77372149 | ||
Human spiral artery renin-angiotensin system | Q77418886 | ||
Angiotensin-(1-7) can interact with the rat proximal tubule AT(4) receptor system | Q78009526 | ||
Angiotensin-(1-7) in normal and preeclamptic pregnancy | Q78568866 | ||
Regional flow-pressure relationship in response to angiotensin in the intact dog and sheep | Q78778708 | ||
Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences | Q79260245 | ||
Angiotensin II decreases system A amino acid transporter activity in human placental villous fragments through AT1 receptor activation | Q79760387 | ||
P433 | issue | 9 | |
P921 | main subject | pre-eclampsia | Q61335 |
P304 | page(s) | 763-771 | |
P577 | publication date | 2008-08-08 | |
P1433 | published in | Placenta | Q7200288 |
P1476 | title | The functional role of the renin-angiotensin system in pregnancy and preeclampsia | |
P478 | volume | 29 |
Q58086125 | (Pro)Renin Receptor Contributes to Pregnancy-Induced Sodium-Water Retention in Rats via Activation of Intrarenal RAAS and α-ENaC |
Q49842182 | A novel rodent model of pregnancy complications associated with genetically determined angiotensin converting enzyme (ACE) activity |
Q36821881 | A review on angiogenesis and its assays |
Q38652773 | Adrenal responses of large whales: Integrating fecal aldosterone as a complementary biomarker to glucocorticoids |
Q51007388 | Androgen levels are associated with blood pressure in pregnant women after term. |
Q38065919 | Angiotensin II type I receptor A1166C polymorphism increases the risk of pregnancy hypertensive disorders: Evidence from a meta-analysis |
Q64111458 | Angiotensin II type i receptor agonistic autoantibodies induces apoptosis of cardiomyocytes by downregulating miR21 in preeclampsia: a mechanism study |
Q52874355 | Angiotensin converting enzyme intron 16 insertion/deletion genotype is associated with plasma C-reactive protein concentration in uteroplacental dysfunction. |
Q42491285 | Arteriolar reactivity in lymphocyte-deficient mice |
Q58095884 | Association between intraoperative phenylephrine administration and umbilical artery pH in women with hypertensive disorders of pregnancy: a retrospective cohort study |
Q90284671 | Association of ACE I/D and AGTR1 A1166C Gene Polymorphisms and Risk of Uterine Leiomyoma: A Case-Control Study |
Q35131064 | Association of angiotensin-converting enzyme intron 16 insertion/deletion and angiotensin II type 1 receptor A1166C gene polymorphisms with preeclampsia in South East of Iran |
Q53059887 | Association of angiotensin-converting enzyme intron 16 insertion/deletion polymorphism with history of foetal loss. |
Q29147510 | Association of dysfunctional synapse defective 1 (SYDE1) with restricted fetal growth - SYDE1 regulates placental cell migration and invasion |
Q26828906 | Association of maternal AGTR1 polymorphisms and preeclampsia: a systematic review and meta-analysis |
Q36295552 | Associations of ACE I/D, AGT M235T gene polymorphisms with pregnancy induced hypertension in Chinese population: a meta-analysis |
Q41633601 | Associations of Angiotensin-Converting Enzyme Insertion/Deletion, Angiotensin II Receptor A1166C, and Endothelial Nitric Oxide Synthase 4b/a Gene Polymorphisms With Pregnancy Hypertensive Disorders: A Meta-Analysis |
Q34040357 | Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia |
Q38542456 | Cardiac Physiology of Pregnancy |
Q47546219 | Contribution of angiotensinogen M235T and T174M gene variants and haplotypes to preeclampsia and its severity in (North African) Tunisians |
Q38389172 | Correlation of ACE gene deletion/insertion polymorphism and risk of pregnancy-induced hypertension: a meta-analysis based on 10,236 subjects |
Q37801273 | Could uric acid have a pathogenic role in pre-eclampsia? |
Q88711642 | Decompensated Heart Failure in Pregnancy |
Q64970125 | Diagnostic Indicators of Superimposed Preeclampsia in Women With CKD. |
Q37996960 | Dynamic proteome in enigmatic preeclampsia: an account of molecular mechanisms and biomarker discovery |
Q54243943 | Eccrine Poroma with Rapid Growth during Pregnancy: A Case Report and Review of the Literature. |
Q92190610 | Effect of Vitamin D supplementation during pregnancy on maternal and perinatal outcomes |
Q33847163 | Effective prediction of preeclampsia by measuring serum angiotensin II, urinary angiotensinogen and urinary transforming growth factor β1. |
Q44455143 | Effects of caesarean section on serum levels of NT-proBNP. |
Q35040354 | Endothelium-dependent relaxation and angiotensin II sensitivity in experimental preeclampsia |
Q36611683 | Expression of the renin-angiotensin system in a human placental cell line |
Q21261491 | Fetal ERAP2 variation is associated with preeclampsia in African Americans in a case-control study |
Q47280931 | Formation of high-molecular-weight angiotensinogen during pregnancy is a result of competing redox reactions with the proform of eosinophil major basic protein. |
Q53760495 | Genophenotypic analysis of angiotensinogen gene M235T polymorphism and preeclampsia. |
Q89854036 | Heart rate variability and hematological parameters in pregnant women |
Q56985613 | Hemodynamic and neurohumoral profile in patients with different types of hypertension in pregnancy |
Q47695443 | Increased B-type natriuretic peptide levels in early-onset versus late-onset preeclampsia |
Q37850374 | Inflammatory pattern recognition receptors and their ligands: factors contributing to the pathogenesis of preeclampsia |
Q35962053 | Inhibitory Effect of the Punica granatum Fruit Extract on Angiotensin-II Type I Receptor and Thromboxane B2 in Endothelial Cells Induced by Plasma from Preeclamptic Patients |
Q92962644 | Is urinary excretion of plasminogen associated with development of pre-eclampsia? An observational, explorative case-control study |
Q37959563 | Linking preeclampsia and cardiovascular disease later in life |
Q38543831 | Linking the old and new -- do angiotensin II type 1 receptor antibodies provide the missing link in the pathophysiology of preeclampsia? |
Q57127734 | Lower circulating angiotensin II levels are related to the severity of preeclampsia and its risk as disclosed by a specific bioassay |
Q64108020 | Maternal Venous Hemodynamic Dysfunction in Proteinuric Gestational Hypertension: Evidence and Implications |
Q35930861 | Molecular regulation of human placental growth factor (PlGF) gene expression in placental villi and trophoblast cells is mediated via the protein kinase a pathway |
Q35820851 | Nutrient availability, the microbiome, and intestinal transport during pregnancy. |
Q40356250 | Onset and Regression of Pregnancy-Induced Cardiac Alterations in Gestationally Hypertensive Mice: The Role of the Natriuretic Peptide System |
Q38067474 | Physiology of the female reproductive axis |
Q36907975 | Placental Vacuolar ATPase Function Is a Key Link between Multiple Causes of Preeclampsia |
Q56019568 | Pre-eclampsia |
Q43699926 | Preeclampsia: effect on newborn blood pressure in the 3 days following preterm birth: a cohort study |
Q37832764 | Preeclamptic nephropathy |
Q88960880 | Pregnancy upregulates angiotensin type 2 receptor expression and increases blood flow in uterine arteries of rats |
Q91607245 | Pregnancy-associated cardiac dysfunction and the regulatory role of microRNAs |
Q36537709 | RAS in Pregnancy and Preeclampsia and Eclampsia |
Q35363716 | Regulation of soluble fms-like tyrosine kinase-1 production in response to placental ischemia/hypoxia: role of angiotensin II. |
Q88493279 | Regulators of G protein signaling in cardiovascular function during pregnancy |
Q54487483 | Renal tubular acidosis type 4 in pregnancy. |
Q38649391 | Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases |
Q37010375 | Significant correlation of angiotensin converting enzyme and glycoprotein IIIa genes polymorphisms with unexplained recurrent pregnancy loss in north of Iran |
Q35574735 | Similarities and differences of X and Y chromosome homologous genes, SRY and SOX3, in regulating the renin-angiotensin system promoters. |
Q37502586 | Stanniocalcin-1 Hormone in Nonpreeclamptic and Preeclamptic Pregnancy: Clinical, Life-Style, and Genetic Modulators |
Q33895023 | The Gene Variants of Maternal/Fetal Renin-Angiotensin System in Preeclampsia: A Hybrid Case-Parent/Mother-Control Study |
Q39196073 | The Impact of Pregnancy on Taste Function |
Q54391063 | The associations between maternal and fetal angiotensinogen M235T polymorphism and pregnancy-induced hypertension in Chinese women. |
Q33591058 | The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia |
Q50750428 | The expression of renin-angiotensin-aldosterone axis components in infantile hemangioma tissue and the impact of propranolol treatment. |
Q46238341 | The pharmacology of preventing Preeclampsia |
Q35939313 | The rat placental renin-angiotensin system - a gestational gene expression study. |
Q37041658 | The role of angiogenic, anti-angiogenic and vasoactive factors in pre-eclamptic African women: early- versus late-onset pre-eclampsia |
Q35767073 | The role of chorionic cytotrophoblasts in the smooth chorion fusion with parietal decidua. |
Q33909763 | The role of vitamin D in pre-eclampsia: a systematic review |
Q38193086 | Tissue Renin-Angiotensin systems: a unifying hypothesis of metabolic disease |
Q37605081 | Trimester Pattern of Change and Reference Ranges of Hematological Profile Among Sudanese Women with Normal Pregnancy |
Q38502483 | Urinary proteomics analysis for renal injury in hypertensive disorders of pregnancy with iTRAQ labeling and LC-MS/MS. |
Search more.